Skip to main content
Article

COVID-19 webinars – Implications for insurance, business risk, people and capital

Risk & Analytics|Future of Work
N/A

April 6, 2020

Stay in touch with the latest thinking from insurance, risk, people and capital experts from across Willis Towers Watson.

Recent Webcasts

How to manage the continuing impact of COVID-19 on employees’ physical and mental health

In this webinar we looked at the continuing impact and challenges of COVID-19 on employee health and wellbeing, and reviewed some of the risks which arise from home working from the perspective of both mental health and physical health.

Watch the replay

Back to top


Construction insurance market update - the reaction to COVID-19

How has the pandemic impacted an already hardening construction insurance market? Find out and hear our predictions for the future.

Watch the replay

Back to top


Reimagine how you fund and buy insurance

It is time to reimagine how you fund risk and buy insurance? On this webinar we discuss how your organisation is dealing with increased financial challenges resulting from the economic downturn.

Watch the replay

Back to top


COVID-19 and the Health and Social Care sector

The COVID-19 outbreak has caused an unprecedented health pandemic which will continue to have evolving economic and societal impacts for a considerable amount of time. Watch the webinar replay where we discuss the regulatory risks and claims defensibility during COVID-19 and beyond.

Watch the replay

Back to top


COVID-19 - Has our risk landscape changed?

How has the risk landscape changed for the retail industry as a result of the pandemic?

Watch the replay

Back to top


COVID-19 virtual workshops

29 April

  • COVID-19 - have you reviewed your cyber risks in the current environment?
  • Watch the replay
  • Crisis management and business continuity: Are you ready to recover?
  • Watch the replay
Contact Us

COVID-19 Webcast replays

 


Additional Insights

Quick access to all of Willis Towers Watson's coverage of COVID-19 (Coronavirus) insights and research